➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Merck
AstraZeneca
Moodys
Boehringer Ingelheim

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Patent: 5,304,489

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,304,489
Title: DNA sequences to target proteins to the mammary gland for efficient secretion
Abstract:Described is a method of targeting specific genes to the mammary gland which results in the efficient synthesis and secretion of biologically important molecules. Further, there is described as a composition of matter, a transgenic mammal having the ability to reproduce itself and being suitable for the secretion of biologically active agents into its milk. Additionally there is disclosed as a composition of matter, recombinant DNA gene complexes designed to integrate into a mammalian genome and to synthesize and secrete biological active agents into the milk. Furthermore methods of producing and using altered milk are disclosed.
Inventor(s): Rosen; Jeffrey M. (Houston, TX)
Assignee: GenPharm International, Inc. (Mountain View, CA)
Application Number:07/602,066
Patent Claims:see list of patent claims

Details for Patent 5,304,489

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ⤷  Try it Free GenPharm International, Inc. (Mountain View, CA) 2011-04-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ⤷  Try it Free GenPharm International, Inc. (Mountain View, CA) 2011-04-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ⤷  Try it Free GenPharm International, Inc. (Mountain View, CA) 2011-04-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 5,304,489

Country Patent Number Estimated Expiration
United States of America 2002023276 ⤷  Try it Free
United States of America 2004266711 ⤷  Try it Free
United States of America 5565362 ⤷  Try it Free
United States of America 5994616 ⤷  Try it Free
Japan 2863789 ⤷  Try it Free
Japan S63309192 ⤷  Try it Free
European Patent Office 0279582 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Dow
Harvard Business School
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.